Asarfi Hospital Ltd
Incorporated in 2005, Asarfi Hospital Ltd
provides primary health services & treatment
and specialized super speciality health service[1]
- Market Cap ₹ 390 Cr.
- Current Price ₹ 198
- High / Low ₹ 257 / 115
- Stock P/E 23.4
- Book Value ₹ 49.6
- Dividend Yield 0.00 %
- ROCE 18.6 %
- ROE 18.6 %
- Face Value ₹ 10.0
Pros
- Company is expected to give good quarter
- Company's working capital requirements have reduced from 24.2 days to 19.3 days
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 13.2% over last 3 years.
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| 81 | 116 | 174 | |
| 65 | 93 | 138 | |
| Operating Profit | 16 | 24 | 35 |
| OPM % | 20% | 20% | 20% |
| 2 | 8 | 3 | |
| Interest | 3 | 4 | 4 |
| Depreciation | 9 | 13 | 12 |
| Profit before tax | 6 | 14 | 22 |
| Tax % | 33% | 26% | 25% |
| 4 | 11 | 17 | |
| EPS in Rs | 2.11 | 5.38 | 8.47 |
| Dividend Payout % | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 49% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 62% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 59% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 13% |
| Last Year: | 19% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Equity Capital | 20 | 20 | 20 |
| Reserves | 51 | 61 | 78 |
| 32 | 49 | 58 | |
| 52 | 34 | 38 | |
| Total Liabilities | 154 | 164 | 193 |
| 94 | 102 | 108 | |
| CWIP | 0 | 2 | 2 |
| Investments | 0 | 0 | 0 |
| 60 | 60 | 83 | |
| Total Assets | 154 | 164 | 193 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| 26 | -4 | 18 | |
| -63 | -7 | -18 | |
| 36 | 13 | 5 | |
| Net Cash Flow | -1 | 1 | 5 |
| Free Cash Flow | -20 | -15 | 0 |
| CFO/OP | 163% | -5% | 68% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Debtor Days | 109 | 125 | 114 |
| Inventory Days | 32 | 30 | 30 |
| Days Payable | 447 | 171 | 156 |
| Cash Conversion Cycle | -305 | -16 | -12 |
| Working Capital Days | 3 | 50 | 19 |
| ROCE % | 16% | 19% |
Insights
In beta| Mar 2014 | Mar 2016 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| Bed Capacity Number of beds ・Standalone data |
|
||||||
| In-patient (IPD) Volume Number of patients ・Standalone data |
|||||||
| Out-patient (OPD) Volume Number of patients ・Standalone data |
|||||||
| Super-Specialty ARPOB INR ・Standalone data |
|||||||
| Super-Specialty Hospital Bed Occupancy Rate % ・Standalone data |
|||||||
| Total Medical Professionals (Doctors) Number ・Standalone data |
|||||||
| Cancer Hospital ARPOB INR ・Standalone data |
|||||||
| Cancer Hospital Average Length of Stay (ALOS) Days ・Standalone data |
|||||||
| Cancer Hospital Bed Occupancy Rate % ・Standalone data |
|||||||
| Nursing and Support Staff Number ・Standalone data |
|||||||
| Super-Specialty Average Length of Stay (ALOS) Days ・Standalone data |
|||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
21 May - Analyst/investor meeting rescheduled to May 27, 2026 for FY26 audited results discussion.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
20 May - The Company has scheduled a Conference Call with Analysts / Investors on Monday, May 25, 2026 at 04:00 P.M. (IST), inter alia, to discuss the …
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
12 May - Asarfi Hospital announced audited Q4/FY26 standalone and consolidated results; FY26 revenue rose 42% to Rs 173.2 Cr.
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
12 May - Asarfi Hospital published audited Q4 and FY26 standalone and consolidated results, showing strong revenue and profit growth.
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
11 May - Asarfi Hospital published audited Q4 and FY26 standalone and consolidated results on 11 May 2026.
Annual reports
Concalls
-
May 2026TranscriptAI SummaryPPT
-
Feb 2026TranscriptAI SummaryPPT
-
Nov 2025Transcript PPT
-
Aug 2025TranscriptAI SummaryPPT
-
May 2025Transcript PPT
-
Jan 2025TranscriptAI SummaryPPT
-
Nov 2024Transcript PPT
Business Overview Asarfi Hospital Limited (AHL) operates three primary facilities:
a) Super Multi-Specialty Hospital (Baramuri, Dhanbad)[1]
- Structure and Capacity: This hospital spans four blocks and six floors, with a constructed area exceeding 100,000 square feet on 92 decimals of land. It houses 250 beds, with plans to expand capacity to 350 beds.
- Specializations: Cardiology and Neurology are major departments, generating nearly 50% of hospital revenue. Other key specialties include emergency care, general medicine, pediatrics, orthopedics, and obstetrics & gynecology.
b) Asarfi Cancer Institute (Ranguni, Dhanbad)[2]
- Location and Size: Built on 9.55 acres of leased land from the Jharkhand Industrial Area Development Authority (JIADA).
- Capacity and Occupancy: Currently, the Cancer Institute operates with 50 beds across two floors, achieving an average occupancy rate of 57% as of H1 FY25. Plans are underway to expand capacity to 150 beds with an additional investment of ₹2-3 crores.
- Unique Positioning: It is the only dedicated cancer hospital within a 200 km radius, offering specialized oncology services including medical, surgical, and radiation oncology.
- Future Expansion: The facility is approved for construction of up to seven floors, enabling substantial expansion.
c) Research Institute (Ranchi)[3]
- Location and Infrastructure: Located 4 km from Ranchi Airport, in proximity to HEC India, on 5.6 acres of acquired land for 13.5 Crs
- Development Plans: AHL plans to establish medical and non-medical research management courses by FY28. The land’s value has appreciated since its acquisition, estimated at ₹65 crores.